Prelude Capital Management’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-700
Closed -$73K 1960
2017
Q2
$73K Sell
700
-692
-50% -$74.3K 0.01% 875
2017
Q1
$178K Buy
1,392
+809
+139% +$85.3K 0.02% 603
2016
Q4
$52K Buy
583
+250
+75% +$18.9K 0.01% 1035
2016
Q3
$25K Buy
+333
New +$24.1K ﹤0.01% 1296
2015
Q3
Sell
-183
Closed -$17K 1867
2015
Q2
$17K Sell
183
-850
-82% -$86.1K ﹤0.01% 1466
2015
Q1
$114K Buy
+1,033
New +$121K 0.02% 954

Other funds holding ARAV

Prelude Capital Management's ARAV Position: Q3 2017 in Review

Prelude Capital Management sold out of Aravive, Inc. Common Stock (ARAV) in Q3 2017, closing a stake of 700 shares — an estimated $73K sold.

Prelude Capital Management first reported a position in ARAV in Q1 2015 and held it in 6 quarters. The position peaked at $178K in Q1 2017. 105 funds tracked by Wall St. Rank hold ARAV as of Q3 2017.

  • Prelude Capital Management reported no remaining Aravive, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Prelude Capital Management sold 700 Aravive, Inc. Common Stock shares in Q3 2017, an estimated $73K.
  • Prelude Capital Management first reported a position in Aravive, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
  • Prelude Capital Management's Aravive, Inc. Common Stock position peaked at $178K in Q1 2017.
  • 105 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q3 2017.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.